About Index Trending news
Analyze
Top 50 Pricing
ImmunoPhotonics

ImmunoPhotonics

Work at ImmunoPhotonics? Add yourself to this profile

ImmunoPhotonics

Developing a novel immunotherapy inCVAX, a minimally invasive vaccine that intends to cause a systemic antitumor response to treat late-stage metastatic cancers

Elsewhere

Alexa global traffic share

Twitter followers

03 Sep 2014
$1,800,000
Venture capital (Series A)